▲ S&P 500 +---% | ▲ Stock Advisor +---% Join The Motley Fool

Accessibility Log In Help

Daily Stock Gainers Daily Stock Losers Most Active Stocks

Daily Stock Gainers Daily Stock Losers Most Active Stocks

Brian Feroldi

TMFTypeoh

Brian Feroldi has been covering the healthcare and technology industries for The Motley Fool since 2015. Brian's investing strategy is to buy high-quality companies and then let compounding work its magic. See all of his articles here.

Recent Articles by Brian Feroldi

Screen Shot 2016-08-10 at 2.55.45 PM

Aug 10, 2016 by Brian Feroldi

Why AMAG Pharmaceuticals, Inc. Is Tanking Today

Shares fall despite reporting a second quarter earnings beat.

alfx

Aug 10, 2016 by Brian Feroldi

TransEnterix Inc Q2 Earnings Show Reasons for Optimism, but the Clock Is Ticking

TransEnterix's second-quarter loss was lower than expected, and the company reported its first ALF-X sale, but is it too little, too late?

Aug 10, 2016 by Brian Feroldi

Why Spectrum Pharmaceuticals, Inc. Is in the Red Today

Shares plunge in the wake of the company reporting second-quarter earnings.

regn

Aug 10, 2016 by Brian Feroldi

Regeneron Pharmaceuticals Inc.'s Q2 Earnings -- It's Still All About Eylea, but Not for Too Much Longer

The biotech heavyweight's earnings rose yet again solely because of strong Eylea sales, but there's potential for new drugs to hit the market soon that could help to carry the growth torch.

Scientist looking at microscope cancer research

Aug 9, 2016 by Brian Feroldi

Why Array BioPharma Inc. Is Plunging Today

Failure in a key clinical trial caused shares to tank.

GettyImages-536308707

Aug 9, 2016 by Brian Feroldi

Horizon Global Corp.'s Margin Gains Cause Profits to Surge

Net income more than doubles in the second quarter, indicating the company's long-term growth strategy is starting to pay off.

GettyImages-116377885

Aug 9, 2016 by Brian Feroldi

Why Nevro Corp. Is Up Big Today

Shares jumped in response to blowout quarterly results.

GettyImages-474957352

Aug 9, 2016 by Brian Feroldi

Why Castlight Health Inc Is Surging Today

Shares pop in response to an upbeat second-quarter earnings report.

GettyImages-87457899

Nov 26, 2018 by Brian Feroldi, Sean Williams, Jason Hall, Neha Chamaria, Steve Symington, Timothy Green, and Todd Campbell

7 Top Stocks to Buy in August

The market may be at frothy levels, but our team of contributors think that these punished stocks are undervalued buys.

board-453758_1280

Aug 4, 2016 by Brian Feroldi

FormFactor, Inc. Bounces Back

The company reported profit and earnings growth well ahead of expectations and issued a bullish outlook.

courthouse-1223279_1920

Aug 3, 2016 by Brian Feroldi

RPX Corporation's Profits Fall Yet Again

Acquisitions helped to fuel big gains on the top line, but the company failed to translate that growth into higher earnings.

CFR

Aug 3, 2016 by Brian Feroldi

Cullen/Frost Bankers' Q2 Energy Losses Slow: Is the Worst Over?

Cullen/Frost Bankers results hint that the worst of damage from the energy downturn might finally be in the rearview mirror.

GettyImages-540215536

Dec 15, 2016 by Brian Feroldi

These 3 Dividend Stocks Are Ridiculously Cheap

These three companies are cheap and offer big dividend yields, but are they worth buying?

GettyImages-516105446

Jul 29, 2016 by Brian Feroldi

Ellie Mae Posts Strong Growth, Raises Guidance

The mortgage-processing software specialist posts impressive results and bumps its full-year guidance.

GettyImages-511875426

Jul 29, 2016 by Brian Feroldi

Why Seres Therapeutics Inc. Is Being Obliterated Today

Shares plunged in reaction to important study results that missed the mark.

Dollar signs in a drug packet

Jul 29, 2016 by Brian Feroldi

Better Buy: Regeneron Pharmaceuticals vs. Pfizer

Both are top healthcare stocks with strong pipelines.

Image by Tax Credits via Flickr

Jul 28, 2016 by Brian Feroldi

3 Stocks That Could Lose You a Lot of Money

These three companies are selling on the cheap, but I'd still suggest that investors stay away.

Screen Shot 2016-07-28 at 3.12.21 PM

Jul 28, 2016 by Brian Feroldi

Why Novocure Ltd Is Plunging Today

Shares drop sharply in response to a disappointing second-quarter earnings report.

GettyImages-493071639

Jul 28, 2016 by Brian Feroldi

Why Infinera Is Being Obliterated Today

Shares plunge in response to management's forecast of a steep drop in revenue.

GettyImages-468340908

Jul 28, 2016 by Brian Feroldi

NetSuite Inc's Shares Soar on News of an Oracle Buyout

Oracle has agreed to buy NetSuite for $9.3 billion.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services